To evaluate and analyze the scientificity, transparency and applicability of Chinese dermatological guidelines and consensus published in medical journals in 2022.

Guidelines and consensus developed by Chinese experts and published in the field of dermatology in 2022 were searched and screened in electronic databases including CNKI, Wanfang Data, SinoMed, Chinese Medical Journal Network, Medline (PubMed), Web of Science, etc. These guidelines and consensus were rated by qualified members of the Scientificity, Transparency and Applicability Rankings (STAR) -Dermatology Professional Committee using the STAR tool. Each guideline or consensus was independently evaluated and cross-checked by 2 evaluators. Guideline and consensus scores and the proportion of scores by fields and items were calculated.

A total of 11 guidelines and 23 consensus statements published in Chinese or English were included. Their STAR scores ranged from 4.3 to 84.6 points, with a median score of 20.7 points (inter-quartile range Q₁-Q₃, 12.7 - 29.3) and a mean score of 24.7 points. The 3 fields with relatively high scores were "Recommendations" (44.9%), "Others" (44.1%) and "Working Group" (31.8%), and the 3 fields with relatively low scores were "Plans" (3.7%), "Funding" (9.8%) and "Registration" (11.8%). The item with the highest score was that clear references could be identified for the main recommendations (94.1%), and the item with the lowest score was that plans were accessible on open-source platforms (e.g., plans could be obtained from registry platforms or websites) (0) .

The quality of Chinese dermatological guidelines and consensus needs to be improved, and it is recommended to pay more attention to the development of standardized guidelines and consensus.

Dermatology; Guideline; Consensus; Comprehensive evaluation